CD81 and hepatocellular carcinoma: We failed to detect any significant increase in P-ERM following anti-CD81 ligation of hepatoma cells, however, this is likely due to elevated P-ERM expression in these cells (Figure 4c) that may mask changes following CD81 ligation.